Hispec innovative drugs to be included in the priority review

On February 20, hisic announced that the ciprofol emulsion injection of Sichuan hisic Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, was included in the list of "publicity of proposed priority review varieties" by the drug review center of the State Drug Administration, and the publicity deadline is February 27, 2020 Cyclophenol emulsion injection is a brand-new intravenous anesthesia drug with independent intellectual property rights developed by the company, which is intended to be used for general anesthesia induction in surgery, sedation / anesthesia in endoscopic diagnosis and treatment, and sedation in ICU and other indications On July 29, 2019, SDA accepted the application for new drugs (special approval procedures) for the indication of "gastrointestinal endoscopy diagnosis and treatment of sedation and / or anesthesia", and on August 2, 2019, it undertook the application for drug registration submitted by the company On January 19, 2020, SDA accepted the application for "general anesthesia induction" indication new drug (special approval procedure), and on January 22, 2020, it undertook the drug registration application submitted by the company Adorable adorable